US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Post-market: 223.000.00000.00%17:06 EDT

Volume:802.02K

Turnover:173.82M

Market Cap:562.96M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.52M

Float Shares:2.52M

Volume Ratio:1.52

T/O Rate:31.77%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Aveanna Healthcare Holdings (AVAH) Gets a Buy from Barclays

PTC Therapeutics (PTCT) Gets a Buy from Barclays

Sotera Health (SHC) Gets a Buy from RBC Capital

NIB Holdings Seeks ASX Quotation for New Dividend Plan Shares

Macquarie Remains a Buy on HealthCo Healthcare & Wellness REIT (HCW)

Analyst Maintains Buy on Enliven, Citing FDA-Aligned Phase III ENABLE-2 Trial and Valuation Disconnect as Attractive Entry Point

Health Care Down on Rotation to Utilities

HeartSciences Secures FDA Clearance for MyoVista wavECG

Bausch + Lomb to Advance Eye Disease Treatment Following FDA Meeting

Health Care Roundup: Market Talk

Press Release: Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Is Debt Refinancing Altering The Investment Case For Tenet Healthcare Stock?

Simply Wall St.

How FDA Inspection Success At WuXi Biologics Stock Has Changed Its Investment Story

Simply Wall St.

Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Falls 11.07% in Regular Trading, Leveraged Biotech ETF Under Pressure from Rate Hike Concerns

Health Care Roundup: Market Talk

Alignment Healthcare put volume heavy and directionally bearish

GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint

MT Newswires Live

Analysts Are Bullish on Top Healthcare Stocks: Alector (ALEC), McKesson (MCK)

Conexeu provides update on FDA 510 premarket notification for Ten Minute Tissue

GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":802022,"hourTrading":{"tag":"盘后","latestPrice":223,"preClose":223,"latestTime":"17:06 EDT","volume":569,"amount":126923.71757,"timestamp":1791493590537,"change":0,"changeRate":0,"amplitude":0.008969},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Post-Mkt","change":-4.75,"latestTime":"10-08 17:07:05 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":173817816.939,"amplitude":0.072746,"askPrice":223.5,"askSize":4,"bidPrice":221.67,"bidSize":400,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":230.529,"aum":581967299.18,"dividendRate":0.004085,"bidAskSpread":0.002401,"preHourTrading":{"tag":"盘前","latestPrice":220.18,"preClose":227.75,"latestTime":"09:29 EDT","volume":6169,"amount":1385605.45651,"timestamp":1791466199999,"change":-7.57,"changeRate":-0.033238,"amplitude":0.038727},"postHourTrading":{"tag":"盘后","latestPrice":223,"preClose":223,"latestTime":"17:06 EDT","volume":569,"amount":126923.71757,"timestamp":1791493590537,"change":0,"changeRate":0,"amplitude":0.008969},"volumeRatio":1.520589,"impliedVol":1.0277,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.520589,"shares":2524486,"dividePrice":0.911,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"committee":0.980198,"eps":0,"divideRate":0.004085,"volume":802022,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673472096","title":"Aveanna Healthcare Holdings (AVAH) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673472096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673472096?lang=en_us&edition=fundamental","pubTime":"2026-10-07 16:06","pubTimestamp":1791360386,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Aveanna Healthcare Holdings, with a price target of $15.00. Acc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aveanna-healthcare-holdings-avah-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aveanna-healthcare-holdings-avah-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CFA","BK4588","BK4581","BK4585","XLV","BK4196","XBI","AVAH","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673538096","title":"PTC Therapeutics (PTCT) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673538096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673538096?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:57","pubTimestamp":1791359860,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle maintained a Buy rating on PTC Therapeutics today and set a price target of $122.00. Merle covers the Healthcare sect...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ptc-therapeutics-ptct-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ptc-therapeutics-ptct-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4585","BK4139","LU0889565916.HKD","LABU","PTCT","XBI","LU0320765992.SGD","BK4588","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673064189","title":"Sotera Health (SHC) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673064189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673064189?lang=en_us&edition=fundamental","pubTime":"2026-10-07 09:49","pubTimestamp":1791337789,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Ryan Halsted maintained a Buy rating on Sotera Health yesterday and set a price target of $24.00. Halsted covers the Healthcare...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sotera-health-shc-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sotera-health-shc-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSIB","LU0708994859.HKD","BK4585","SHC","BK4207","LU0310800379.SGD","LU0029864427.USD","LU0128525929.USD","LU1267930573.SGD","BK4581","XLV","BK4121","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673061934","title":"NIB Holdings Seeks ASX Quotation for New Dividend Plan Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673061934","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673061934?lang=en_us&edition=fundamental","pubTime":"2026-10-07 08:27","pubTimestamp":1791332878,"startTime":"0","endTime":"0","summary":"NIB Holdings Ltd ( ($AU:NHF) ) has issued an update. NIB Holdings Limited is an Australian listed health insurance provider focused on offering pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nib-holdings-seeks-asx-quotation-for-new-dividend-plan-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nib-holdings-seeks-asx-quotation-for-new-dividend-plan-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","UNHW","UNHG","IHF","UNHU","XBI","XLV","UN","BK4581","LABU","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673660930","title":"Macquarie Remains a Buy on HealthCo Healthcare & Wellness REIT (HCW)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673660930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673660930?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:36","pubTimestamp":1791326179,"startTime":"0","endTime":"0","summary":"Macquarie analyst maintained a Buy rating on HealthCo Healthcare & Wellness REIT today and set a price target of A$1.10. Currently, the analyst con...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/macquarie-remains-a-buy-on-healthco-healthcare-wellness-reit-hcw-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/macquarie-remains-a-buy-on-healthco-healthcare-wellness-reit-hcw-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REIT","IVRA","PSCF","MDIV","XLV","YLDW","BK4585","BK4588","XBI","BK4581","BPRE","LABU","RNTY","DFRA","RJMG","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673066216","title":"Analyst Maintains Buy on Enliven, Citing FDA-Aligned Phase III ENABLE-2 Trial and Valuation Disconnect as Attractive Entry Point","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066216","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066216?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:15","pubTimestamp":1791324929,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh has reiterated their bullish stance on ELVN stock, giving a Buy rating yesterday. Andy Hsieh has given his Buy rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-enliven-citing-fda-aligned-phase-iii-enable-2-trial-and-valuation-disconnect-as-attractive-entry-point-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-enliven-citing-fda-aligned-phase-iii-enable-2-trial-and-valuation-disconnect-as-attractive-entry-point-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673066503","title":"Health Care Down on Rotation to Utilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066503?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:44","pubTimestamp":1791323040,"startTime":"0","endTime":"0","summary":"Health-care companies ticked down as a rotation to other defensive sectors offset deal activity.Investment firm CD&R and drug wholesaler McKesson agreed to buy Option Care Health, a provider of infusi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XBI","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065096","title":"HeartSciences Secures FDA Clearance for MyoVista wavECG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065096","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065096?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:02","pubTimestamp":1791320554,"startTime":"0","endTime":"0","summary":"Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an announcement. On October 6, 2026, HeartSciences announced that the U.S. Food and Drug Adm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heartsciences-secures-fda-clearance-for-myovista-wavecg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heartsciences-secures-fda-clearance-for-myovista-wavecg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673406595","title":"Bausch + Lomb to Advance Eye Disease Treatment Following FDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673406595","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673406595?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:51","pubTimestamp":1791319860,"startTime":"0","endTime":"0","summary":"Bausch + Lomb said it plans to advance one of its eye disease treatments following a meeting with the Food and Drug Administration it described as constructive.The eye health company said the FDA meeting gave clarity on the development path of BL1243, or tonabersat, a treatment of dry age-related macular degeneration.The FDA was supportive in principle of a proposed initial study design, the company said, adding that results from the initial study are expected to support advancement into a phase 2 study. The clinical program in dry AMD is expected to launch in 2027.\"The oral route of administration, prior clinical experience and potential application in earlier-stage disease make BL1243 a particularly compelling program as we continue building the next generation of treatments for eye health,\" Chief Medical Officer Yehia Hashad said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065930","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065930?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:50","pubTimestamp":1791319800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0310 ET - Sanofi needs mergers and acquisitions to refill its la","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","XLV","XBI","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673479063","title":"Press Release: Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673479063","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673479063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:15","pubTimestamp":1791317700,"startTime":"0","endTime":"0","summary":"Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segmentsProceeds strengthen balance sheet and enhance financial flexibilityLONDON, Oct. 6, 2026 /PRNewsw","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0128526141.USD","BK4588","XLV","XBI","CLVT","BK4585","HCSG","BK4561","LU0029874061.USD","LABU","BK4137","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673680220","title":"Is Debt Refinancing Altering The Investment Case For Tenet Healthcare Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673680220","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673680220?lang=en_us&edition=fundamental","pubTime":"2026-10-07 03:18","pubTimestamp":1791314282,"startTime":"0","endTime":"0","summary":"Tenet Healthcare has issued US$2b of 6.250% senior notes due 2034, with the proceeds intended to redeem US$1.5b of 5.125% secured notes due 2027 and US$500m of 6.125% notes due 2028, reshaping its long term debt stack.\nThis refinancing moves Tenet Healthcare toward longer dated unsecured borrowing while leaving room for additional indebtedness, which affects future flexibility for hospital investments, ambulatory surgery center expansion and ongoing share repurchases.\nWe will look at how...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-debt-refinancing-altering-the-investment-case-for-tenet-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-debt-refinancing-altering-the-investment-case-for-tenet-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0963586101.USD","HCSG","LU2324357040.USD","BK4585","BK4588","LU0130103400.USD","LU1201861165.SGD","THC","XBI","LU0648000940.SGD","XLV","LU0029874061.USD","BK4581","LU0128526141.USD","BK4185","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673106644","title":"How FDA Inspection Success At WuXi Biologics Stock Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2673106644","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673106644?lang=en_us&edition=fundamental","pubTime":"2026-10-07 02:20","pubTimestamp":1791310833,"startTime":"0","endTime":"0","summary":"WuXi Biologics reported that its Wuxi Mashan drug substance and drug product facilities completed an unannounced two week FDA GMP inspection in September 2026, covering multiple FDA approved biologics and confirming compliance for supplying commercial products to the U.S. market.\nThe Wuxi Mashan site combines drug substance and drug product manufacturing on one campus, which can reduce handoff risk, simplify tech transfers, and support more efficient commercial scale supply for complex...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/how-fda-inspection-success-at-wuxi-biologics-stock-has-chang","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/how-fda-inspection-success-at-wuxi-biologics-stock-has-chang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0128522744.USD","LU0211977185.USD","LU0181495838.USD","LU0540923850.HKD","BK1521","LU1794554557.SGD","LU0708995583.HKD","LU0516423174.USD","LU2039709279.SGD","LU0516422440.USD","BK1610","LU0052750758.USD","LU0320764599.SGD","LU0359201612.USD","LU0856984785.SGD","LU0417516902.SGD","BK1576","LU1242518931.SGD","LU0326950275.SGD","LU0708995153.HKD","LU0979878070.USD","LU0516423091.SGD","BK4588","LABU","LU0417516738.SGD","LU2476274308.USD","LU2778985437.USD","LU0307460666.USD","LU0572944931.SGD","LU0051755006.USD","LU0456827905.SGD","LU1688375341.USD","LU3063872942.SGD","BK1141","LU1242518857.USD","SG9999002463.SGD","LU0561508036.HKD","LU0348825331.USD","LU2476274720.SGD","KURE","LU0348735423.USD","LU0634319403.HKD","BK4585","LU0359202008.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","SG9999002562.SGD","LU0516422366.SGD","02269","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192672167","title":"Movement Alert｜Direxion Daily S&P Biotech Bull 3x Shares Falls 11.07% in Regular Trading, Leveraged Biotech ETF Under Pressure from Rate Hike Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1192672167","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192672167?lang=en_us&edition=fundamental","pubTime":"2026-10-07 01:41","pubTimestamp":1791308512,"startTime":"0","endTime":"0","summary":"On October 7, Direxion Daily S&P Biotech Bull 3x Shares fell 11.07% in regular trading, trading at $228.895/share, with Turnover of $198 million.The decline reflects mounting pressure across the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Biotech Bull 3x ETF Slides as Rate Hike Fears Spike","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673570710","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2673570710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673570710?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:20","pubTimestamp":1791303600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0310 ET - Sanofi needs mergers and acquisitions to refill its la","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","BK4588","XBI","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673052130","title":"Alignment Healthcare put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2673052130","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673052130?lang=en_us&edition=fundamental","pubTime":"2026-10-06 22:55","pubTimestamp":1791298526,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Alignment Healthcare (ALHC) with 4,339 puts trading, or 4x expected. Most active are Oct-26 10 puts and Oct-26 7.5 puts, with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alignment-healthcare-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","XBI","BK4585","BK4588","BK4581","BK4154","XLV","ALHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673054830","title":"GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054830","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673054830?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:42","pubTimestamp":1791294162,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, which is majority owned by GSK , said Tuesday that a phase 3b study has met its primary endpoint, showing that at six months, Cabenuva saw \"superior rates of viral suppression\" compared with oral antiretroviral therapy in adults and adolescents with HIV-1, who had detectable virus when they started the trial.The trial has enrolled 326 participants in eight countries at 85 study sites, the company said.The results follow a previous trial that showed that Cabenuva was superior to daily oral therapy in keeping viral suppression for people with HIV who had reached viral suppression on oral antiretroviral therapy but had a history of adherence challenges, ViiV said.The latest trial addressed a \"remaining evidence gap by evaluating direct initiation of the regimen in people who still had detectable virus at study entry,\" the company said.ViiV said the latest results will now be shared with health regulators.Price: 46.77, Change: +0.24, Percent Change: +0.52","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","BK4581","BK4137","GSK","BK4585","LU1829250122.USD","LABU","GSKH","BK4588","LU0029874061.USD","GSK.UK","XBI","XLV","BK4007","HCSG","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051007","title":"Analysts Are Bullish on Top Healthcare Stocks: Alector (ALEC), McKesson (MCK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051007?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:30","pubTimestamp":1791293429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alector (ALEC) and McKesson (MCK) with bullish senti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-alector-alec-mckesson-mck-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-alector-alec-mckesson-mck-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0251131958.USD","LU0203347892.USD","LU0965509283.SGD","LU0742534661.SGD","LU2112291526.USD","LU1037948897.HKD","LU1506573853.SGD","LU1934455194.USD","LU0689626769.HKD","LU1023059063.AUD","MCK","LU0942090050.USD","LU0965508806.USD","LU1983260115.SGD","BK4585","LU2324357040.USD","LU0029874061.USD","LU0965509010.AUD","LU0965509101.SGD","HCSG","LU0868494617.USD","LU1585245621.USD","LU0251142724.SGD","LU0861579265.USD","LU0203345920.USD","LU2089984988.USD","LU1814569148.SGD","LU1934455863.HKD","LU0122379950.USD","BK4533","XBI","LU1061106388.HKD","LU0048573561.USD","LU0124676726.USD","BK4581","LU1366192091.USD","LABU","BK4588","LU0868494708.USD","LU1430594728.SGD","BK4139","LU1934455277.USD","XLV","LU0882574055.USD","BK4175","LU1037948541.HKD","LU0342679015.USD","LU0114720955.EUR","ALEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051138","title":"Conexeu provides update on FDA 510 premarket notification for Ten Minute Tissue","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051138?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:12","pubTimestamp":1791292341,"startTime":"0","endTime":"0","summary":"Conexeu Sciences (CNXU) provided an update on the regulatory and manufacturing program supporting its planned FDA 510 premarket notification for Te...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/conexeu-provides-update-on-fda-510-premarket-notification-for-ten-minute-tissue-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/conexeu-provides-update-on-fda-510-premarket-notification-for-ten-minute-tissue-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNXU","LABU","EES","BK4139","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051943","title":"GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051943","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051943?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:10","pubTimestamp":1791292244,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), with Shionogi as a shareholder, announced the phase IIIb CROWN stud...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","LU0128526141.USD","XLV","HCSG","BK4007","GSK","BK4581","XBI","LABU","BK4137","BK4532","BK4588","LU1829250122.USD","GSKH","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":5,"totalSize":430,"code":"91000000","status":"200"}]}}